This one should have move up to the high 80's or mid 90's, because there were not a big sell off. I believe it was shorts using options, plus maybe some dilution. The float is low. The product were not disapprove by the FDA because of bad testing for a medical procedure, but the medical diagnostic test is not more equivalent to what is out in the USA medical field. I'm sure this is a glitch that APPY can make correct and receive an approve from the FDA.IMO they probably need to explain and show how the test is more easier to use, more safer than using X-Rays to diagnosis Appendicitis on the body, especially for children. Maybe use a different approach than the appendicitis testing that is already being us by hospital doctor. Add or reduce a few more steps, show that APPYl is a much better test to apply than what is already out.
Europe board of medicine and equipment approve the APPYl appendicitis test. I think the next time around Venaxis will get a FDA Approval for it Appendicitis testing procedure.
All in my humble opinion only.
